Choose Your Country or Region

N-(Hytroxymethy)micotinamide

Name: N-(Hytroxymethy)micotinamide
Brand: Selleck Chemicals
SKU: S5390
Rating: 5 (1 reviews)

Synonyms: Nikomethamide, Bilamid, N-hydroxymethylnicotinamide

Catalog No.S5390 Purity: 99.88%

N-(Hydroxymethyl)nicotinamide (Nikomethamide, Bilamid, N-hydroxymethylnicotinamide) is an antimicrobial agent.

N-(Hytroxymethy)micotinamide Chemical Structure

CAS: 3569-99-1

Purity & Quality Control

Batch: S539001 DMSO] 30 mg/mL] false] ] ] false] ] ] false Purity: 99.88%

99.88

N-(Hytroxymethy)micotinamide Related Products

Related Products	Clorsulon Azithromycin Dihydrate Mefloquine HCl Sodium Tauroursodeoxycholate (TUDC) Delafloxacin (ABT-492) Chlorhexidine Cinchonidine Berberine chloride hydrate Chlorquinaldol Prednisolone disodium phosphate p-Coumaric Acid Ascomycin (FK520) Proguanil LL37 (Human cathelicidin) Primaquine Diphosphate Lumefantrine Cetrimonium Bromide (CTAB) Nitidine Chloride Lauric Acid Chlorhexidine diacetate Chlorhexidine 2HCl Olsalazine Sodium Cetylpyridinium Chloride Rheochrysidin Sulfacetamide Sodium Secnidazole Broxyquinoline Ethacridine lactate monohydrate Maackiain SulfadiMethoxine sodium Imidocarb dipropionate Polyphyllin B (Formosanin C)	Click to Expand
Related Compound Libraries	Anti-infection Compound Library Antibiotics compound Library Antiviral Compound Library Anti-parasitic Compound Library Gut Microbial Metabolite Library	Click to Expand

Choose Selective Anti-infection Inhibitors

Biological Activity

Description	N-(Hydroxymethyl)nicotinamide (Nikomethamide, Bilamid, N-hydroxymethylnicotinamide) is an antimicrobial agent.

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT05312372	Withdrawn	Esophageal Squamous Cell Carcinoma	Institut de Recherches Internationales Servier\|ADIR a Servier Group company\|Servier	May 2025	Phase 1\|Phase 2
NCT03806751	Not yet recruiting	Validation of a New Noninvasive Method to Obtain the Arterial Input Function (AIF) Directly by PET Imaging	University of Alabama at Birmingham	February 1 2025	Early Phase 1
NCT04933422	Not yet recruiting	Glioblastoma	Crimson Biopharm Inc.	January 2025	Phase 1
NCT05082584	Suspended	Anemia of Chronic Kidney Disease	Akebia Therapeutics	January 2025	Phase 3
NCT05082571	Suspended	Anemia of Chronic Kidney Disease	Akebia Therapeutics	January 2025	Phase 3
NCT05039892	Not yet recruiting	CholangiocarcinomaAdult	3D Medicines (Beijing) Co. Ltd.\|3D Medicines	December 2024	Phase 2

Chemical Information & Solubility

Molecular Weight	152.15	Formula	C₇H₈N₂O₂
CAS No.	3569-99-1	SDF	--
Smiles	C1=CC(=CN=C1)C(=O)NCO
Storage (From the date of receipt)	3 years -20°C powder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years -20°C powder		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 30 mg/mL ( (197.17 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):